ANAITA PANTHAKY: Open Payments
NPI 1508317843 · LOMA LINDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,010 in 56 payments from 17 companies in 2025. Trend: 2023 $392 · 2024 $950 · 2025 $2,010
Food & beverage: $2,010
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $488 |
| Novartis Pharmaceuticals Corporation | 13 | $305 |
| Edwards Lifesciences Corporation | 2 | $238 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $187 |
| Regeneron Healthcare Solutions, Inc. | 4 | $124 |
| Alnylam Pharmaceuticals Inc. | 5 | $122 |
| E.R. Squibb & Sons, L.L.C. | 5 | $103 |
| Amgen Inc. | 4 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
| Merck Sharp & Dohme LLC | 3 | $70 |
Products named: Rapiblyk, LEQVIO, SAPIEN 3 Ultra RESILIA, JARDIANCE, EVKEEZA, AMVUTTRA, Repatha, Kerendia.
Industry payments across CA — which companies pay providers there.
